chr3:36993226:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr3:37,034,717-37,092,387 |
hg38 | chr3:36,993,226-37,050,896 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.009 | renal cell carcinoma | NA | BeFree,GAD,LHGDN | Detail | |
0.031 | squamous cell carcinoma | The hMLH1 -93G>A promoter polymorphism is associates with outcomes in oral squam... | BeFree,GAD,LHGDN | 25047469 | Detail |
0.031 | squamous cell carcinoma | We examined the influence of MLH1 c.-93G>A, MSH2 c.211 + 9C>G, MSH3 c.3133G>A an... | BeFree,GAD,LHGDN | 25598504 | Detail |
0.002 | Carcinoma, Transitional Cell | NA | BeFree | Detail | |
<0.001 | celiac disease | NA | BeFree | Detail | |
<0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
<0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
<0.001 | colitis | NA | BeFree | Detail | |
0.012 | ulcerative colitis | NA | BeFree,GAD,LHGDN | Detail | |
0.029 | Colonic Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Colonic Polyps | NA | BeFree,LHGDN | Detail | |
0.230 | Colorectal Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.240 | Hereditary nonpolyposis colorectal neoplasms | NA | CTD_human,GAD,LHGDN | Detail | |
0.004 | Crohn Disease | NA | BeFree,LHGDN | Detail | |
<0.001 | Phyllodes Tumor | NA | BeFree | Detail | |
0.002 | DNA Damage | NA | GAD | Detail | |
<0.001 | Endocrine Gland Neoplasms | NA | BeFree | Detail | |
0.023 | Endometrial Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.001 | endometrial hyperplasia | NA | BeFree | Detail | |
<0.001 | endometriosis | NA | BeFree | Detail | |
0.003 | Esophageal Diseases | NA | BeFree,LHGDN | Detail | |
0.003 | Esophageal Neoplasms | NA | BeFree,GAD | Detail | |
0.001 | Fanconi anemia | NA | BeFree | Detail | |
<0.001 | fragile X syndrome | NA | BeFree | Detail | |
<0.001 | Friedreich ataxia | We propose that upregulation of MLH1 or PMS2 could be potential FRDA therapeutic... | BeFree | 24971578 | Detail |
0.005 | gastritis | NA | LHGDN | Detail | |
0.002 | Gastritis, Atrophic | NA | GAD | Detail | |
0.008 | Gastrointestinal Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Genital Neoplasms, Female | NA | BeFree,GAD | Detail | |
0.002 | glioblastoma | Formerly, we found evidence of prognostic impact of MLH1 and MSH6 immunohistoche... | BeFree | 24995467 | Detail |
0.001 | Glioma | These families all had at least 2 verified glioma cases and a third reported or ... | BeFree | 24723567 | Detail |
0.001 | Glioma | MutL homolog 1 contributes to temozolomide-induced autophagy via ataxia-telangie... | BeFree | 25646660 | Detail |
<0.001 | granulosa cell tumor | NA | BeFree | Detail | |
0.003 | Head and Neck Neoplasms | NA | LHGDN | Detail | |
0.003 | hepatitis | NA | LHGDN | Detail | |
<0.001 | hepatitis A | NA | BeFree | Detail | |
<0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
<0.001 | HIV Infections | NA | BeFree | Detail | |
0.003 | Hodgkin Disease | NA | BeFree,GAD | Detail | |
<0.001 | Huntington disease | Association at MLH1 and pathway analysis of the full GWA results support a role ... | BeFree | 26232222 | Detail |
0.003 | Inflammatory Bowel Diseases | NA | BeFree,GAD | Detail | |
<0.001 | insulinoma | NA | BeFree | Detail | |
<0.001 | Intestinal Neoplasms | NA | BeFree | Detail | |
<0.001 | irritable bowel syndrome | NA | BeFree | Detail | |
<0.001 | keratoacanthoma | NA | BeFree | Detail | |
0.015 | leukemia | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | chronic lymphocytic leukemia | NA | BeFree,LHGDN | Detail | |
<0.001 | lymphoid leukemia | NA | BeFree | Detail | |
<0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
0.013 | Leukemia, Myelocytic, Acute | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
<0.001 | Leukemia, Plasma Cell | NA | BeFree | Detail | |
<0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
<0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
0.003 | Leukoplakia | NA | BeFree,LHGDN | Detail | |
<0.001 | liposarcoma | NA | BeFree | Detail | |
<0.001 | Alcoholic Liver Diseases | NA | BeFree | Detail | |
0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
0.085 | Lung Neoplasms | NA | LHGDN,RGD | Detail | |
<0.001 | Lymphatic Metastasis | NA | BeFree | Detail | |
0.125 | lymphoma | NA | BeFree,CTD_human,LHGDN | Detail | |
0.003 | Lymphoma, Follicular | The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who d... | BeFree,GAD | 25596266 | Detail |
0.025 | Malignant neoplasm of stomach | Mismatch repair was affected by a mutation of MLH1 in 1 GC and by aberrant methy... | BeFree,GAD | 24510342 | Detail |
0.025 | Malignant neoplasm of stomach | Predictive value of CHFR and MLH1 methylation in human gastric cancer. | BeFree,GAD | 24748501 | Detail |
0.025 | Malignant neoplasm of stomach | TP53 mutation, allelic deletion of the APC gene and nuclear staining of β-cateni... | BeFree,GAD | 26033320 | Detail |
0.017 | melanoma | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Monoclonal Gammopathy of Undetermined Significance | NA | BeFree | Detail | |
<0.001 | multiple myeloma | NA | BeFree | Detail | |
0.003 | mycosis fungoides | NA | BeFree,LHGDN | Detail | |
<0.001 | Myotonic dystrophy | NA | BeFree | Detail | |
0.125 | Neoplasm Metastasis | NA | BeFree,CTD_human,LHGDN | Detail | |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
0.121 | Neoplastic Syndromes, Hereditary | HNPCC is an autosomal inherited cancer syndrome characterized by germinal and so... | BeFree,CLINVAR | 25200962 | Detail |
<0.001 | nephroblastoma | NA | BeFree | Detail | |
0.002 | neurofibromatosis 1 | NA | BeFree | Detail | |
<0.001 | oligospermia | NA | BeFree | Detail | |
0.010 | ovarian carcinoma | Similarly, women with mutations in the DNA mismatch repair genes, MLH1, MSH2, MS... | BeFree | 25238946 | Detail |
0.010 | ovarian carcinoma | Pyrosequencing analyses confirmed that SGI-110 caused both global (LINE1) and ge... | BeFree | 25316809 | Detail |
0.007 | Pancreatic Neoplasm | NA | GAD | Detail | |
<0.001 | plasmacytoma | NA | BeFree | Detail | |
0.007 | Adenomatous Polyposis Coli | NA | BeFree | Detail | |
0.013 | polyps | These polyps contain BRAF mutations and are prone to epigenetic methylation that... | BeFree,LHGDN | 25602793 | Detail |
0.013 | polyps | CpG methylation of MLH1 often leads to reduced or lost expression in dysplastic ... | BeFree,LHGDN | 26030242 | Detail |
<0.001 | Precancerous Conditions | NA | BeFree | Detail | |
0.125 | Prostatic Neoplasms | NA | CTD_human,LHGDN | Detail | |
0.003 | Rectal Neoplasms | NA | BeFree,GAD | Detail | |
<0.001 | retinoblastoma | NA | BeFree | Detail | |
<0.001 | Sandhoff disease | NA | BeFree | Detail | |
<0.001 | seminoma | NA | BeFree | Detail | |
<0.001 | Skin Diseases, Genetic | NA | BeFree | Detail | |
<0.001 | Skin Neoplasms | NA | BeFree | Detail | |
0.002 | Carcinoma of bladder | We examined the associations between bladder cancer and 7 polymorphisms from 5 g... | BeFree | 22927776 | Detail |
0.012 | Malignant neoplasm of urinary bladder | We examined the associations between bladder cancer and 7 polymorphisms from 5 g... | BeFree | 22927776 | Detail |
0.022 | Stomach Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | synovial sarcoma | NA | LHGDN | Detail | |
0.005 | Thyroid Neoplasm | NA | BeFree,GAD | Detail | |
<0.001 | viral hepatitis | NA | BeFree | Detail | |
0.002 | Helicobacter Infections | NA | GAD | Detail | |
<0.001 | Ichthyosis, X-Linked | NA | BeFree | Detail | |
0.003 | B-Cell Lymphomas | NA | BeFree,LHGDN | Detail | |
0.003 | diffuse large B-cell lymphoma | NA | BeFree,GAD | Detail | |
<0.001 | Immunoblastic Large-Cell Lymphoma | NA | BeFree | Detail | |
0.082 | colorectal carcinoma | Ten non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently... | BeFree | 18619730 | Detail |
0.160 | colorectal cancer | Ten non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently... | BeFree | 18619730 | Detail |
0.005 | Neoplasms, Second Primary | NA | GAD | Detail | |
<0.001 | Polyendocrinopathies, Autoimmune | NA | BeFree | Detail | |
<0.001 | cecum carcinoma | NA | BeFree | Detail | |
<0.001 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Gastric adenoma | NA | BeFree | Detail | |
0.001 | Cutaneous Melanoma | We found an association between the risk of CMM and peripheral blood mononuclear... | BeFree | 25026000 | Detail |
<0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
<0.001 | esophageal carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gallbladder | NA | BeFree | Detail | |
<0.001 | uterine cancer | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of testis | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | endometriosis of ovary | NA | BeFree | Detail | |
<0.001 | Aortic Aneurysm, Thoracic | NA | BeFree | Detail | |
0.003 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | Undifferentiated carcinoma | NA | BeFree | Detail | |
<0.001 | Germ cell tumor | NA | BeFree | Detail | |
0.003 | adenomyoma | NA | LHGDN | Detail | |
<0.001 | Sarcoma, Clear Cell | NA | BeFree | Detail | |
<0.001 | alveolar soft part sarcoma | NA | BeFree | Detail | |
<0.001 | Adenoma, Villous | NA | BeFree | Detail | |
<0.001 | Adenomatous Polyps | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma, Clear Cell | NA | BeFree | Detail | |
0.001 | sebaceous adenocarcinoma | We report the case of a 52-year-old caucasian woman with the development of meta... | BeFree | 25197397 | Detail |
0.001 | sebaceous adenocarcinoma | Eighteen (56%) of the 32 specimens with SA or SC displayed MMR-protein deficienc... | BeFree | 25457183 | Detail |
0.004 | Carcinoma, Endometrioid | NA | BeFree,LHGDN | Detail | |
0.003 | Medullary carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Cervical Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
<0.001 | gallbladder carcinoma | NA | BeFree | Detail | |
0.002 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | Gastrointestinal Stromal Tumors | NA | BeFree | Detail | |
<0.001 | Hereditary pancreatitis | NA | BeFree | Detail | |
<0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
0.001 | Multiple tumors | NA | BeFree | Detail | |
0.492 | Turcot syndrome (disorder) | Tumor MMR-deficiency was observed for 22 cases [69 %; 95 % confidence interval (... | BeFree,CLINVAR,CTD_human,ORPHANET,UNIPROT | 25117503 | Detail |
0.492 | Turcot syndrome (disorder) | This study compared two biomarkers in tumours with mismatch repair deficiency; q... | BeFree,CLINVAR,CTD_human,ORPHANET,UNIPROT | 25280751 | Detail |
0.492 | Turcot syndrome (disorder) | Thus, a case with the clinical condition of hereditary non-polyposis colorectal ... | BeFree,CLINVAR,CTD_human,ORPHANET,UNIPROT | 25716099 | Detail |
0.492 | Turcot syndrome (disorder) | This study provides statistical evidence that MMR deficiency is correlated with ... | BeFree,CLINVAR,CTD_human,ORPHANET,UNIPROT | 25938433 | Detail |
<0.001 | Stage II Colon Cancer | NA | BeFree | Detail | |
<0.001 | Malignant Childhood Neoplasm | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of small intestine | NA | BeFree | Detail | |
<0.001 | Metastatic melanoma | NA | BeFree | Detail | |
<0.001 | Cancer of Head and Neck | NA | BeFree | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
<0.001 | Lobular carcinoma in situ of breast | NA | BeFree | Detail | |
0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
<0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | Loss of MLH1 confers resistance to PI3Kβ inhibitors in renal clear cell carcinom... | BeFree | 25528216 | Detail |
<0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | laryngeal squamous cell carcinoma | NA | BeFree | Detail | |
0.001 | cervix carcinoma | NA | BeFree | Detail | |
0.003 | Hyperplastic Polyp | NA | BeFree | Detail | |
0.014 | Multiple polyps | NA | BeFree | Detail | |
<0.001 | tubular adenomas and adenocarcinomas | NA | BeFree | Detail | |
<0.001 | Non-infiltrating lobular carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of liver | NA | BeFree,GAD | Detail | |
<0.001 | intrahepatic cholangiocarcinoma | NA | BeFree | Detail | |
<0.001 | Breast Cancer, Familial | NA | BeFree | Detail | |
<0.001 | Endometrioid carcinoma ovary | NA | BeFree | Detail | |
<0.001 | intestinal cancer | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of pancreas | NA | BeFree,GAD | Detail | |
<0.001 | Atypical endometrial hyperplasia | NA | BeFree | Detail | |
0.012 | Malignant neoplasm of prostate | Prostate cancers (mean age at diagnosis = 62 ± SD = 8 years) from 32 MMR mutatio... | BeFree,GAD | 25117503 | Detail |
0.012 | Malignant neoplasm of prostate | DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. | BeFree,GAD | 25526032 | Detail |
0.012 | Malignant neoplasm of prostate | This study provides statistical evidence that MMR deficiency is correlated with ... | BeFree,GAD | 25938433 | Detail |
0.004 | Hematologic Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | Congenital Myotonic Dystrophy | NA | BeFree | Detail | |
0.037 | endometrial carcinoma | This review shows that BRAF mutations occurs so infrequently in endometrial tumo... | BeFree,GAD | 23880961 | Detail |
0.037 | endometrial carcinoma | Endometrial cancers from 173 patients recruited to the Nanchong Central Hospital... | BeFree,GAD | 25400828 | Detail |
0.037 | endometrial carcinoma | MSI is also observed in about 15 % of sporadic colorectal cancer (CRC), gastric ... | BeFree,GAD | 25701956 | Detail |
0.037 | endometrial carcinoma | Our results suggest that the -93G>A polymorphism of the hMLH1 gene singly and in... | BeFree,GAD | 25804231 | Detail |
0.037 | endometrial carcinoma | Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients Wit... | BeFree,GAD | 25871621 | Detail |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Recurrent tumor | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of esophagus | NA | BeFree,GAD | Detail | |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Ewings sarcoma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of skin | NA | BeFree | Detail | |
<0.001 | Carcinoma of larynx | NA | BeFree | Detail | |
0.025 | Carcinogenesis | As one of the most essential components of mismatch repair system, MutL homolog ... | BeFree | 25986311 | Detail |
<0.001 | Lymphoid neoplasm | NA | BeFree | Detail | |
0.003 | prostate carcinoma | Prostate cancers (mean age at diagnosis = 62 ± SD = 8 years) from 32 MMR mutatio... | BeFree | 25117503 | Detail |
0.003 | prostate carcinoma | DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. | BeFree | 25526032 | Detail |
0.003 | prostate carcinoma | This study provides statistical evidence that MMR deficiency is correlated with ... | BeFree | 25938433 | Detail |
0.001 | Hereditary Breast and Ovarian Cancer Syndrome | NA | BeFree | Detail | |
0.006 | Epithelial ovarian cancer | MLH1 was methylated in 37.5% and 64.3% EOCs and LMP tumors. | BeFree,GAD | 25192888 | Detail |
0.008 | breast carcinoma | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.004 | Secondary malignant neoplasm of lymph node | We reviewed clinicopathological findings (age, gender, tumor size, gross appeara... | BeFree | 25759539 | Detail |
0.020 | colon carcinoma | The most common hereditary colon cancer susceptibility condition, Lynch syndrome... | BeFree | 24051481 | Detail |
0.020 | colon carcinoma | When stratified by tumor location, hMLH1 -93G>A and IVS3-1403A>T were associated... | BeFree | 24793746 | Detail |
0.020 | colon carcinoma | Among all the 32 families with mutations, families with hMSH2 mutation had a hig... | BeFree | 25216868 | Detail |
0.020 | colon carcinoma | A novel deletion in the splice donor site of MLH1 exon 6 in a Japanese colon can... | BeFree | 26185136 | Detail |
0.017 | stomach carcinoma | Mismatch repair was affected by a mutation of MLH1 in 1 GC and by aberrant methy... | BeFree | 24510342 | Detail |
0.017 | stomach carcinoma | Predictive value of CHFR and MLH1 methylation in human gastric cancer. | BeFree | 24748501 | Detail |
0.017 | stomach carcinoma | TP53 mutation, allelic deletion of the APC gene and nuclear staining of β-cateni... | BeFree | 26033320 | Detail |
0.002 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
<0.001 | biliary tract cancer | NA | BeFree | Detail | |
<0.001 | Brain Tumor, Primary | NA | BeFree | Detail | |
<0.001 | Cancer of Urinary Tract | NA | BeFree | Detail | |
<0.001 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Malignant Squamous Cell Neoplasm | NA | BeFree | Detail | |
<0.001 | Stage I Endometrial Carcinoma | NA | BeFree | Detail | |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
<0.001 | Advanced cancer | NA | BeFree | Detail | |
0.133 | ovarian neoplasm | Only 4 cases (12.5%) that had specific MMR protein loss showed the same type of ... | BeFree,CTD_human,LHGDN | 25695547 | Detail |
0.014 | Microsatellite Instability | NA | GAD | Detail | |
<0.001 | precancerous lesions | NA | BeFree | Detail | |
<0.001 | Ovarian adenocarcinoma | NA | BeFree | Detail | |
0.001 | Polyp of large intestine | NA | BeFree | Detail | |
<0.001 | Papillomavirus Infections | NA | BeFree | Detail | |
<0.001 | Invasive Ductal Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Monoclonal Gammapathies | NA | BeFree | Detail | |
0.015 | Malignant neoplasm of ovary | Similarly, women with mutations in the DNA mismatch repair genes, MLH1, MSH2, MS... | BeFree,GAD | 25238946 | Detail |
0.015 | Malignant neoplasm of ovary | Pyrosequencing analyses confirmed that SGI-110 caused both global (LINE1) and ge... | BeFree,GAD | 25316809 | Detail |
0.003 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
0.004 | sarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Traditional Serrated Adenoma | NA | BeFree | Detail | |
0.003 | Adenoma of large intestine | NA | BeFree,GAD | Detail | |
<0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
0.366 | Torre-Muir syndrome | Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related ... | BeFree,CLINVAR,CTD_human,ORPHANET | 25197397 | Detail |
0.002 | Hereditary Malignant Neoplasm | NA | BeFree | Detail | |
<0.001 | Grade 3 Colorectal Adenocarcinoma | This raises the question whether these morphological subtypes should be maintain... | BeFree | 25339302 | Detail |
<0.001 | Invasive Carcinoma | NA | BeFree | Detail | |
<0.001 | Opisthorchis Viverrini-Related Cholangiocarcinoma | NA | BeFree | Detail | |
<0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Primary Carcinoma | NA | BeFree | Detail | |
<0.001 | Sporadic Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Testicular Germ Cell Tumor | NA | BeFree | Detail | |
<0.001 | renal carcinoma | NA | BeFree | Detail | |
0.012 | Mammary Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Low Grade Cervical Squamous Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | Ductal Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Rectal Tumors | NA | BeFree | Detail | |
<0.001 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma, Endometrioid | NA | BeFree | Detail | |
<0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
0.002 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
0.120 | Cafe au lait spots, multiple | NA | CTD_human | Detail | |
0.014 | uterine corpus cancer | This review shows that BRAF mutations occurs so infrequently in endometrial tumo... | BeFree | 23880961 | Detail |
0.014 | uterine corpus cancer | Endometrial cancers from 173 patients recruited to the Nanchong Central Hospital... | BeFree | 25400828 | Detail |
0.014 | uterine corpus cancer | MSI is also observed in about 15 % of sporadic colorectal cancer (CRC), gastric ... | BeFree | 25701956 | Detail |
0.014 | uterine corpus cancer | Our results suggest that the -93G>A polymorphism of the hMLH1 gene singly and in... | BeFree | 25804231 | Detail |
<0.001 | Urothelial Carcinoma | NA | BeFree | Detail | |
0.005 | liver carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Sessile Serrated Adenoma/Polyp | The hierarchical tree of this subset of probes revealed two distinct clusters: G... | BeFree | 24964857 | Detail |
<0.001 | Sessile Serrated Adenoma/Polyp | High miR-31 expression, MLH1 methylation and MSI-high status were more frequentl... | BeFree | 25632919 | Detail |
<0.001 | Sessile Serrated Adenoma/Polyp | CpG methylation of MLH1 often leads to reduced or lost expression in dysplastic ... | BeFree | 26030242 | Detail |
<0.001 | Treatment related leukaemia | NA | BeFree | Detail | |
0.002 | Chronic ulcerative colitis | NA | GAD | Detail | |
<0.001 | Pancreatic carcinoma, familial | NA | BeFree | Detail | |
<0.001 | Prostate cancer, familial | NA | BeFree | Detail | |
<0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
<0.001 | Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type | NA | BeFree | Detail | |
<0.001 | Stage II Colon Cancer AJCC v7 | NA | BeFree | Detail | |
<0.001 | Colorectal Serrated Adenocarcinoma | NA | BeFree | Detail | |
0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
0.003 | Infection | NA | LHGDN | Detail | |
<0.001 | Sebaceous gland tumors | NA | BeFree | Detail | |
<0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | oligospermia | One intronic SNP in MLH1 (rs4647269) and two non-synonymous SNPs in PMS2 (rs1059... | BeFree | 22594646 | Detail |
<0.001 | azoospermia | One intronic SNP in MLH1 (rs4647269) and two non-synonymous SNPs in PMS2 (rs1059... | BeFree | 22594646 | Detail |
0.037 | adenocarcinoma | These polyps contain BRAF mutations and are prone to epigenetic methylation that... | BeFree,GAD,LHGDN | 25602793 | Detail |
0.002 | papillary adenocarcinoma | NA | GAD | Detail | |
0.010 | adenoma | We conclude that hypermethylation of MLH1, when occurs in an adenoma cell with B... | BeFree | 24964857 | Detail |
0.010 | adenoma | In particular, MLH1, ATM and FHIT gene promoters were found to be significantly ... | BeFree | 25091577 | Detail |
<0.001 | Astrocytoma | NA | BeFree | Detail | |
<0.001 | azoospermia | NA | BeFree | Detail | |
<0.001 | Barrett esophagus | NA | BeFree | Detail | |
0.012 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
0.003 | Bloom syndrome | NA | LHGDN | Detail | |
0.001 | Brain Neoplasms | The risk of brain tumors was significantly higher (2.5%) in MSH2 gene mutation c... | BeFree | 25648859 | Detail |
0.022 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
<0.001 | Carcinoid Tumor | NA | BeFree | Detail | |
0.024 | Malignant tumor of colon | The most common hereditary colon cancer susceptibility condition, Lynch syndrome... | BeFree | 24051481 | Detail |
0.024 | Malignant tumor of colon | When stratified by tumor location, hMLH1 -93G>A and IVS3-1403A>T were associated... | BeFree | 24793746 | Detail |
0.024 | Malignant tumor of colon | Prostate cancers (mean age at diagnosis = 62 ± SD = 8 years) from 32 MMR mutatio... | BeFree | 25117503 | Detail |
0.024 | Malignant tumor of colon | Among all the 32 families with mutations, families with hMSH2 mutation had a hig... | BeFree | 25216868 | Detail |
0.024 | Malignant tumor of colon | A novel deletion in the splice donor site of MLH1 exon 6 in a Japanese colon can... | BeFree | 26185136 | Detail |
0.014 | Malignant neoplasm of endometrium | This review shows that BRAF mutations occurs so infrequently in endometrial tumo... | BeFree | 23880961 | Detail |
0.014 | Malignant neoplasm of endometrium | Endometrial cancers from 173 patients recruited to the Nanchong Central Hospital... | BeFree | 25400828 | Detail |
0.014 | Malignant neoplasm of endometrium | MSI is also observed in about 15 % of sporadic colorectal cancer (CRC), gastric ... | BeFree | 25701956 | Detail |
0.014 | Malignant neoplasm of endometrium | Our results suggest that the -93G>A polymorphism of the hMLH1 gene singly and in... | BeFree | 25804231 | Detail |
<0.001 | female breast carcinoma | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of larynx | NA | BeFree | Detail | |
0.004 | Rectal Carcinoma | When stratified by tumor location, hMLH1 -93G>A and IVS3-1403A>T were associated... | BeFree | 24793746 | Detail |
<0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
0.005 | mucinous adenocarcinoma | NA | BeFree,LHGDN | Detail | |
0.005 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
0.003 | Carcinoma, Papillary | NA | BeFree,GAD | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
The hMLH1 -93G>A promoter polymorphism is associates with outcomes in oral squamous cell carcinoma p... | DisGeNET | Detail |
We examined the influence of MLH1 c.-93G>A, MSH2 c.211 + 9C>G, MSH3 c.3133G>A and EXO1 c.1765G>A pol... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We propose that upregulation of MLH1 or PMS2 could be potential FRDA therapeutic approaches to incre... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Formerly, we found evidence of prognostic impact of MLH1 and MSH6 immunohistochemical expression in ... | DisGeNET | Detail |
These families all had at least 2 verified glioma cases and a third reported or verified glioma case... | DisGeNET | Detail |
MutL homolog 1 contributes to temozolomide-induced autophagy via ataxia-telangiectasia mutated in gl... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association at MLH1 and pathway analysis of the full GWA results support a role for DNA handling and... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from d... | DisGeNET | Detail |
Mismatch repair was affected by a mutation of MLH1 in 1 GC and by aberrant methylation of MLH1 in 2 ... | DisGeNET | Detail |
Predictive value of CHFR and MLH1 methylation in human gastric cancer. | DisGeNET | Detail |
TP53 mutation, allelic deletion of the APC gene and nuclear staining of β-catenin are frequently det... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HNPCC is an autosomal inherited cancer syndrome characterized by germinal and somatic mutations of D... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Similarly, women with mutations in the DNA mismatch repair genes, MLH1, MSH2, MSH6, or PMS2, associa... | DisGeNET | Detail |
Pyrosequencing analyses confirmed that SGI-110 caused both global (LINE1) and gene-specific hypometh... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These polyps contain BRAF mutations and are prone to epigenetic methylation that ultimately silences... | DisGeNET | Detail |
CpG methylation of MLH1 often leads to reduced or lost expression in dysplastic foci and carcinomas ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We examined the associations between bladder cancer and 7 polymorphisms from 5 genes involved in the... | DisGeNET | Detail |
We examined the associations between bladder cancer and 7 polymorphisms from 5 genes involved in the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Ten non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with col... | DisGeNET | Detail |
Ten non-synonymous single nucleotide polymorphisms (nsSNPs), which were recently associated with col... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We found an association between the risk of CMM and peripheral blood mononuclear cell methylation le... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We report the case of a 52-year-old caucasian woman with the development of metachronous colon cance... | DisGeNET | Detail |
Eighteen (56%) of the 32 specimens with SA or SC displayed MMR-protein deficiency, comprising 17 (65... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Tumor MMR-deficiency was observed for 22 cases [69 %; 95 % confidence interval (CI) 50-83 %], with t... | DisGeNET | Detail |
This study compared two biomarkers in tumours with mismatch repair deficiency; quantification of met... | DisGeNET | Detail |
Thus, a case with the clinical condition of hereditary non-polyposis colorectal cancer as defined by... | DisGeNET | Detail |
This study provides statistical evidence that MMR deficiency is correlated with hypermethylation of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Loss of MLH1 confers resistance to PI3Kβ inhibitors in renal clear cell carcinoma with SETD2 mutatio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Prostate cancers (mean age at diagnosis = 62 ± SD = 8 years) from 32 MMR mutation carriers (23 MSH2,... | DisGeNET | Detail |
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. | DisGeNET | Detail |
This study provides statistical evidence that MMR deficiency is correlated with hypermethylation of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This review shows that BRAF mutations occurs so infrequently in endometrial tumours they can be disc... | DisGeNET | Detail |
Endometrial cancers from 173 patients recruited to the Nanchong Central Hospital were tested for MMR... | DisGeNET | Detail |
MSI is also observed in about 15 % of sporadic colorectal cancer (CRC), gastric cancer (GC), and end... | DisGeNET | Detail |
Our results suggest that the -93G>A polymorphism of the hMLH1 gene singly and in combination with th... | DisGeNET | Detail |
Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and End... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
As one of the most essential components of mismatch repair system, MutL homolog 1 (MLH1) plays an in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Prostate cancers (mean age at diagnosis = 62 ± SD = 8 years) from 32 MMR mutation carriers (23 MSH2,... | DisGeNET | Detail |
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. | DisGeNET | Detail |
This study provides statistical evidence that MMR deficiency is correlated with hypermethylation of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
MLH1 was methylated in 37.5% and 64.3% EOCs and LMP tumors. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We reviewed clinicopathological findings (age, gender, tumor size, gross appearance, histological mo... | DisGeNET | Detail |
The most common hereditary colon cancer susceptibility condition, Lynch syndrome (LS), previously kn... | DisGeNET | Detail |
When stratified by tumor location, hMLH1 -93G>A and IVS3-1403A>T were associated with colon cancer s... | DisGeNET | Detail |
Among all the 32 families with mutations, families with hMSH2 mutation had a higher ratio of synchro... | DisGeNET | Detail |
A novel deletion in the splice donor site of MLH1 exon 6 in a Japanese colon cancer patient with Lyn... | DisGeNET | Detail |
Mismatch repair was affected by a mutation of MLH1 in 1 GC and by aberrant methylation of MLH1 in 2 ... | DisGeNET | Detail |
Predictive value of CHFR and MLH1 methylation in human gastric cancer. | DisGeNET | Detail |
TP53 mutation, allelic deletion of the APC gene and nuclear staining of β-catenin are frequently det... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Only 4 cases (12.5%) that had specific MMR protein loss showed the same type of loss for both endome... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Similarly, women with mutations in the DNA mismatch repair genes, MLH1, MSH2, MSH6, or PMS2, associa... | DisGeNET | Detail |
Pyrosequencing analyses confirmed that SGI-110 caused both global (LINE1) and gene-specific hypometh... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome. | DisGeNET | Detail |
NA | DisGeNET | Detail |
This raises the question whether these morphological subtypes should be maintained or whether an alt... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This review shows that BRAF mutations occurs so infrequently in endometrial tumours they can be disc... | DisGeNET | Detail |
Endometrial cancers from 173 patients recruited to the Nanchong Central Hospital were tested for MMR... | DisGeNET | Detail |
MSI is also observed in about 15 % of sporadic colorectal cancer (CRC), gastric cancer (GC), and end... | DisGeNET | Detail |
Our results suggest that the -93G>A polymorphism of the hMLH1 gene singly and in combination with th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The hierarchical tree of this subset of probes revealed two distinct clusters: Group 1, mostly compo... | DisGeNET | Detail |
High miR-31 expression, MLH1 methylation and MSI-high status were more frequently detected in SSAs f... | DisGeNET | Detail |
CpG methylation of MLH1 often leads to reduced or lost expression in dysplastic foci and carcinomas ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
One intronic SNP in MLH1 (rs4647269) and two non-synonymous SNPs in PMS2 (rs1059060, Ser775Asn) and ... | DisGeNET | Detail |
One intronic SNP in MLH1 (rs4647269) and two non-synonymous SNPs in PMS2 (rs1059060, Ser775Asn) and ... | DisGeNET | Detail |
These polyps contain BRAF mutations and are prone to epigenetic methylation that ultimately silences... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We conclude that hypermethylation of MLH1, when occurs in an adenoma cell with BRAF oncogenic mutati... | DisGeNET | Detail |
In particular, MLH1, ATM and FHIT gene promoters were found to be significantly hypermethylated in r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The risk of brain tumors was significantly higher (2.5%) in MSH2 gene mutation carriers compared to ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The most common hereditary colon cancer susceptibility condition, Lynch syndrome (LS), previously kn... | DisGeNET | Detail |
When stratified by tumor location, hMLH1 -93G>A and IVS3-1403A>T were associated with colon cancer s... | DisGeNET | Detail |
Prostate cancers (mean age at diagnosis = 62 ± SD = 8 years) from 32 MMR mutation carriers (23 MSH2,... | DisGeNET | Detail |
Among all the 32 families with mutations, families with hMSH2 mutation had a higher ratio of synchro... | DisGeNET | Detail |
A novel deletion in the splice donor site of MLH1 exon 6 in a Japanese colon cancer patient with Lyn... | DisGeNET | Detail |
This review shows that BRAF mutations occurs so infrequently in endometrial tumours they can be disc... | DisGeNET | Detail |
Endometrial cancers from 173 patients recruited to the Nanchong Central Hospital were tested for MMR... | DisGeNET | Detail |
MSI is also observed in about 15 % of sporadic colorectal cancer (CRC), gastric cancer (GC), and end... | DisGeNET | Detail |
Our results suggest that the -93G>A polymorphism of the hMLH1 gene singly and in combination with th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
When stratified by tumor location, hMLH1 -93G>A and IVS3-1403A>T were associated with colon cancer s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs1059060 dbSNP
- Genome
- hg38
- Position
- chr3:36,993,226-37,050,896
- Variant Type
- snv
Genome browser